Phuturdex › Diseases › Bronchiolitis obliterans
Drugs in development · updated 30 October 2026
Bronchiolitis obliterans: drugs in development
As of 30 October 2026 there are 2 active clinical trials (recruiting or ongoing, phases I–III) on 6 drugs for bronchiolitis obliterans. 0 are experimental, that is not yet approved in the United States.
Summary updated every week · data as of 30 October 2026. In Phuturdex you get the full detail of every drug and an email when an alert is published on the ones you follow.
Sign in free →Approved drugs in new trials
Approved by the US FDA for at least one indication, not necessarily this disease, and now in active trials on it.
| Drug | Most advanced phase | Active trials | Reference trial |
|---|---|---|---|
| AzithromycinAzasite®, Zithromax® | II | 1 | NCT05922761 |
| BelumosudilRezurock® | II | 1 | NCT05922761 |
| Fluticasone PropionateFluticasone, Xhance® | II | 1 | NCT05922761 |
| MontelukastSingulair® | II | 1 | NCT05922761 |
| PrednisonePredinisone, Cortancyl | II | 1 | NCT05922761 |
| VimseltinibDCC-3014, Romvimza® | II | 1 | NCT06619561 |
Sorted by most advanced phase and number of active trials.
All 6 drugs, with the details
In Phuturdex every drug has all its trials, sponsors and countries, FDA and EMA approvals, orphan designations and safety alerts. Free until 31 March 2027.
Open in Phuturdex →Specific forms
- Bronchiolitis obliterans syndrome 36 drugs
- Graft-versus-host disease 49 drugs
- Hematologic neoplasm 216 drugs
- Autoimmune disease 94 drugs
- Systemic scleroderma 77 drugs
- Systemic lupus erythematosus 178 drugs
- Lupus nephritis 64 drugs
- Chronic lymphocytic leukemia 137 drugs
- Mantle cell lymphoma 108 drugs
- Follicular lymphoma 144 drugs
- Diffuse large B-cell lymphoma 177 drugs
- Waldenstrom Macroglobulinemia 51 drugs
Broader categories
- Bronchitis 6 drugs
- Respiratory disease 57 drugs
- Digestive System Diseases 36 drugs
- Infection 71 drugs
- Respiratory tract infection 46 drugs
- Immune System Diseases 54 drugs
Source: Phuturdex analysis of ClinicalTrials.gov data (U.S. National Library of Medicine), updated 30 October 2026. Active trials = recruiting or ongoing, phases I–III, with at least one identified drug; phase and sites refer to the trials on this disease. Disease name: Wikidata; NLM MeSH term: D001989 “Bronchiolitis Obliterans”.